Public health experts are sounding the alarm over recent move by the NIH to collect information about funding for research into mRNA technology
Stephanie Kirchgaessner in Washington and
Jessica Glenza in New York
Thu 27 Mar 2025 06.00 EDT
Share
A cutting-edge technology expected to foster new medical breakthroughs in treatments for cancers and infectious disease is being treated “like a four-letter word” inside the
Trump administration, causing panic among scientists who fear Trump-appointed health officials, driven by misinformation and conspiracy theories about the Covid-19 vaccine, will cut critical research in the field.
Scientists and public health experts interviewed by the Guardian are sounding the alarm over a recent move by the National Institutes of
Health to collect information about funding for research into mRNA technology.
Some fear it is the first step in a move to cut or defund grants that involve the technology, which was an essential component in the rapid creation of vaccines against Covid-19, a major accomplishment of the first Trump term in fighting the pandemic.
Messenger RNA technology, which in the case of Covid-19 teaches the body to fight infection by introducing immune cells to the coronavirus’s characteristic spike proteins, is being tested for use against diseases ranging from bird flu and dengue, to pancreatic cancer and melanoma.
While the NIH has not formally stated that it is cutting mRNA vaccine and therapy research, scientists who were interviewed by the Guardian said they have been told informally that the NIH is performing key word searches on grants that mention mRNA vaccine-related technology and related phrases.
“Colleagues have also been advised not to apply for mRNA vaccine grants. This is all through the grapevine. There has not been an official statement about it,” said one New York-based scientist.
The NIH confirmed in a statement to the Guardian that it made a “data call” to learn more information about the funding of mRNA vaccine grants. Nature, the scientific journal, first reported the data call, and said it had been conducted by the acting NIH director, Matthew Memoli, on 6 March. Scientists were given one day to report the information, and NIH collected information about 130 mRNA grants as a result.
Many of the scientists, public health experts and medical researchers interviewed by the Guardian spoke on the condition of anonymity, fearing that they might be targeted if they expressed concerns publicly. One former senior NIH official who resigned recently said what was happening inside the organization was “not understandable”.